EFFECTIVENESS AND SAFETY OF ASPIRIN IN SECONDARY PREVENTION OF CARDIOVASCULAR OUTCOMES IN PATIENTS WITH CHRONIC KIDNEY DISEASE: A SUBGROUP ANALYSIS OF ADAPTABLE

Category Primary study
JournalJournal of the American College of Cardiology
Year 2022
This article has no abstract
Epistemonikos ID: 3c0cf7c63a1e8be847d83aeb9a4f11cfef1193e7
First added on: Feb 13, 2025